SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia has been completed, with ...
Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果